Abstract
We propose a rapid and label-free quantitative evaluation of anti-cancer drug efficacy in apoptosis using live cancer cells cultured on a sensor chip. The resultant custom-made, high-precision surface plasmon resonance (SPR) sensor monitors the inner mitochondrial membrane’s potential change (ΔΨm). For trans-membrane anti-cancer drugs to be effective, continuous potential changes arising from the crossing of the membrane by the drug of interest prevent ΔΨm monitoring. Herein, we report on a novel signaling echo method that avoids this disturbance; the cancer cells are incubated with a specific anti-cancer drug, with subsequent removal of the drug before SPR measurements. The cell reaction without any drug was monitored as the differential SPR angle rate of change for 10 min from 30 min after a sensor chip was set on a prism. The cell reaction after 60 min pre-incubation with a drug was significantly related to the conventional cell viability after 48 h (P <0.001).
Similar content being viewed by others
References
American Cancer Association, “Cancer Facts & Figures 2008”, 2009, American Cancer Society, Atlanta, GA.
M. L. Rothenberg, D. P. Carbone, and D. H. Johnson, Nat. Rev. Cancer, 2003, 3, 303.
D. Sidransky, Nat. Rev. Cancer, 2002, 2, 210.
J. E. González and P. A. Negulescu, Curr. Opin. Biotechnol., 1998, 9, 624.
B. D. Gehm, J. M. McAndrews, P. Y. Chien, and J. L. Jamieson, Proc. Natl. Acad. Sci. U. S. A., 1997, 94, 14138.
Q. B. She, W. Y. Ma, M. Wang, A. Kaji, C. T. Ho, and Z. dong, Oncogene, 2003, 22, 2143.
S. B. Le, E. l. Holmuhamedov, V. L. Narayanan, E. A. Sausville, and S. H. Kaufmann, Cell Death Diff., 2006, 13, 151.
A. Kosaihira and T. Ona, Anal. Bioanal. Chem., 2008, 391, 1889.
P S. Moore, B. Sipos, S. Orlandini, C. Sorio, F. X. Real, N. R. Lemoine, T. Gress, C. Bassi, G. Klöppel, H. Kalthoff, H. Ungefroren, M. Löhr, and A. Scarpa, Virchows Arch., 2001, 439, 798.
V. P. Savitskiy, T. V. Shman, and M. P. Potapnev, Cytometry B Clin. Cytom., 2003, 56B, 16.
M. Castedo, K. Ferri, T. Roumier, D. Metivier, N. Zamzami, and G. Kroemer, J. Immunol. Methods, 2002, 265, 39.
d. G. Johnson and C. L. Walker, Annu. Rev. Pharmacol. Toxicol., 1999, 39, 295.
M. Malumbres and M. Barbacid, Nat. Rev. Cancer, 2009, 9, 153.
A. E. Leitch, C. Haslett, and A. G. Rossi, Br. J. Phamacol., 2009, 158, 1004.
T. Abbas and A. Dutta, Nat. Rev. Cancer, 2009, 9, 400.
I. S. Chu, L. Hengst, and J. M. Slingerland, Nat. Rev. Cancer, 2009, 8, 253.
G. I. Shapiro, J. Clin. Oncol., 2006, 24, 1770.
J. Węsierska-Gądek, M. Gueorguieva, J. Wojciechowski, and M. Horky, Pol. J. Pharmacol., 2004, 56, 635.
E. A. Monaco III, C. M. Beaman-Hall, A. Mathur, and M. L. Vallano, Biochem. Pharmacol., 2004, 67, 1947.
J. Wojciechowski, M. Horky, M. Gueorguieva, and J. Węsierska-Gądek, Int. J. Cancer, 2003, 106, 486.
S. Sui, Y. Dong, Y. Watanabe, F. Yamaguchi, N. Hatano, I. Tsukamoto, K. Izumori, and M Tokuda, Int. J. Oncol., 2005, 27, 907.
S. Sui, Y. Dong, Y. Watanabe, F. Yamaguchi, N. Hatano, I. Tsukamoto, K. Izumori, and M. Tokuda, Anticancer Res., 2005, 25, 2639.
M. Yokohira, K. Hosokawa, K. Yamakawa, K. Saoo, Y. Matsuda, Y. Zeng, T. Kuno, and K. Imaida, J. Biosci. Bioeng., 2008, 105, 545.
Y. Dobashi, T. Takehana, and A. Ooi, Curr. Med. Chem., 2003, 10, 2549.
J. A. Pietenpol and Z. A. Stewart, Toxicology, 2002, 182–182, 474.
E. C. Pietsch, S. M. Sykes, S. B. McMahon, and M. E. Murphy, Oncogene, 2008, 27, 6507.
D. R. Green and G. Kroemer, Nature, 2009, 458, 1127.
C. Nylander, B. Liedberg, and T. Lind, Sens. Actuators, 1982/1983, 3, 79.
S. Sjölander and C. Urbaniczky, Anal. Chem., 1991, 63, 2338.
“CRC Handbook of Chemistry and Physics”, ed. R. C. Weast, 67th ed., 1987, CRC Press, Boca Raton, FL, D-218.
S. J. Yoon and D. Kim, J. Opt. Soc. Am. A, 2007, 24, 2543.
A. V. Kuznetsov and R. Margreiter, Int. J. Mol. Sci., 2009, 10, 1911.
T. Liebermann and W. Knoll, Colloid Surf., A, 2000, 171, 115.
S. Ekgasit, C. Thammacharoen, and W. Knoll, Anal. Chem., 2004, 76, 561.
M. Lebiedzinska, G. Szabadkai, A. W. E. Jones, J. Duszynski, and M. R. Wieckowski, Int. J. Biochem. Cell Biol., 2009, 41, 1805.
E. J. Griffiths and G. A. Rutter, Biochem. Biophys. Acta, 2009, 1787, 1342.
B. Sepúlveda, A. Calle, L. M. Lechuga, and G. Armelles, Opt. Lett., 2006, 31, 1085.
S. Salvioli, A. Ardizzoni, C. Franceschi, and A. Cossarizza, FEBS Lett., 1997, 411, 77.
J. Downward, Nature, 2006, 439, 274.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nishijima, H., Kosaihira, A., Shibata, J. et al. Development of Signaling Echo Method for Cell-based Quantitative Efficacy Evaluation of Anti-cancer Drugs in Apoptosis without Drug Presence Using High-precision Surface Plasmon Resonance Sensing. ANAL. SCI. 26, 529–534 (2010). https://doi.org/10.2116/analsci.26.529
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2116/analsci.26.529